FY2026 Earnings Forecast for ENSG Issued By Zacks Research

The Ensign Group, Inc. (NASDAQ:ENSG) – Equities research analysts at Zacks Research upped their FY2026 earnings estimates for shares of The Ensign Group in a research report issued to clients and investors on Tuesday, November 10th. Zacks Research analyst Team now anticipates that the company will post earnings of $7.10 per share for the year, up from their prior forecast of $6.98. The consensus estimate for The Ensign Group’s current full-year earnings is $7.07 per share. Zacks Research also issued estimates for The Ensign Group’s Q4 2026 earnings at $1.92 EPS, Q1 2027 earnings at $1.81 EPS, Q2 2027 earnings at $1.73 EPS, Q3 2027 earnings at $1.91 EPS, Q4 2027 earnings at $1.88 EPS, FY2027 earnings at $7.32 EPS, Q1 2028 earnings at $2.07 EPS, Q2 2028 earnings at $1.87 EPS, Q3 2028 earnings at $2.10 EPS and FY2028 earnings at $8.16 EPS.

The Ensign Group (NASDAQ:ENSG) last issued its earnings results on Tuesday, October 27th. The company reported $2.03 EPS for the quarter, beating the consensus estimate of $1.97 by $0.06. The business had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.51 billion. The Ensign Group had a return on equity of 16.79% and a net margin of 7.03%. The company’s revenue was up 14.5% compared to the same quarter last year. During the same period last year, the business posted $1.64 EPS.

Several other research firms also recently commented on ENSG. Truist Financial set a $210.00 price objective on The Ensign Group and gave the stock a “hold” rating in a report on Thursday, October 29th. Royal Bank Of Canada upped their target price on shares of The Ensign Group from $228.00 to $239.00 and gave the company an “outperform” rating in a research note on Tuesday, November 3rd. Weiss Ratings raised shares of The Ensign Group from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. UBS Group reiterated a “buy” rating and issued a $240.00 price target (up from $230.00) on shares of The Ensign Group in a research note on Thursday, October 29th. Finally, Oppenheimer boosted their price objective on shares of The Ensign Group from $210.00 to $215.00 and gave the company an “outperform” rating in a report on Thursday, October 29th. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $226.00.

The Ensign Group Stock Up 0.6%

ENSG stock opened at $186.19 on Thursday. The stock has a market capitalization of $10.86 billion, a P/E ratio of 27.71, a P/E/G ratio of 1.75 and a beta of 0.66. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.20 and a quick ratio of 1.20. The Ensign Group has a 1-year low of $141.58 and a 1-year high of $218.00. The business has a fifty day moving average price of $175.91 and a 200-day moving average price of $181.79.

The Ensign Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Saturday, October 31st. Investors of record on Wednesday, September 30th were given a dividend of $0.0650 per share. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date was Wednesday, September 30th. The Ensign Group’s dividend payout ratio is 3.87%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of ENSG. BlackRock Inc. bought a new stake in shares of The Ensign Group during the 2nd quarter valued at about $937,218,000. Wasatch Advisors LP boosted its holdings in shares of The Ensign Group by 10.7% in the second quarter. Wasatch Advisors LP now owns 2,278,324 shares of the company’s stock worth $365,215,000 after buying an additional 220,329 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in shares of The Ensign Group by 7.1% in the first quarter. Arrowstreet Capital Limited Partnership now owns 457,667 shares of the company’s stock worth $92,220,000 after buying an additional 30,521 shares during the last quarter. Bank of New York Mellon Corp purchased a new position in shares of The Ensign Group in the second quarter worth approximately $65,470,000. Finally, Paradigm Capital Management Inc. NY bought a new stake in The Ensign Group during the second quarter valued at approximately $54,742,000. Institutional investors own 96.12% of the company’s stock.

The Ensign Group News Roundup

Here’s some of the latest news about ENSG:

• Positive Sentiment: U.S. News & World Report named 101 Ensign-affiliated facilities to its 2027 Best Nursing Homes list; each received a High Performing rating. The recognition may reinforce the company’s reputation for care quality. Article: U.S. News names Ensign affiliates among Best Nursing Homes
• Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $7.10 from $6.98 and FY2027 to $7.32 from $7.26. Several quarterly estimates also increased, suggesting a modestly improved near-term earnings outlook.
• Negative Sentiment: Law firms are publicizing a pending securities class action against Ensign and a December 7 lead-plaintiff deadline. The case covers investors who acquired shares from February 10, 2022 through June 18, 2026; the legal claims create reputational and potential financial uncertainty, though the notices do not establish wrongdoing. Article: Securities class action notice

About The Ensign Group

The Ensign Group, Inc. is a healthcare services company focused on post-acute care and senior living. Through its subsidiaries, it operates skilled nursing and rehabilitation facilities, assisted living communities, and independent living communities. The company also provides home health and hospice services, as well as mobile diagnostics and other ancillary services that support patients and care facilities. Its operations serve communities across multiple U.S. states. Founded in 1999, Ensign has grown from a skilled nursing operator into a broader provider of healthcare and senior services.